Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
(PubMed) Pons R, De Vivo DC
sgRNA constructs and gene expressing codon optimized (OPT) plasmid constructs sgRNA control and constructs against CBS and L2HGDH were designed targeting GTATTACTGATATTGGTGGG (sgControl) (#230080, Addgene), GGAGCAGACAACCTACGAGG (sg CBS -1) (#230081, Addgene), TGGCAGTGCTGGCAGCACGG (sg CBS -2) (#230082, Addgene), GATATAGTCATCGTTGGTGG (sg L2HGDH -1) (#230083, Addgene), and CACCAGACTGGACATAACAG (sg L2HGDH -2) (#230084, Addgene) and constructed in lentiCRISPR v2-Blast (#83480, Addgene) for Blasticidin selection at a final concentration of 5 g/ml
Pharmacodynamic Assessment From a pharmacokinetic standpoint, the two compounds do not share metabolic enzymes
Most healthcare providers follow established clinical protocols when considering growth hormone secretagogues, which typically includes a review of personal and family medical history before any protocol begins
US$ 20.61
US$ 23.73
:max_bytes(150000):strip_icc()/VW-Health-Ozembic-Injection-site-V2-f0e98eb1833f48e898d8a19800fb515f.jpg)
US$ 24.36
US$ 25.39
US$ 21.87
